Every 10-Q that i3 Verticals, Inc. (IIIV) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow IIIV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IIIV filings page.
i3 Verticals, Inc. generated third‑quarter 2026 revenue from continuing operations of $53,067, up from $51,901 a year earlier. Income from continuing operations attributable to the company improved to $3,620 from a loss of $410, and for the nine months ended June 30, 2026 rose to $5,660 from $2,464.
Total net income attributable to i3 Verticals, Inc., including discontinued operations, was $3,482 for the quarter and $5,430 year‑to‑date, below the prior year’s $12,882 and $14,784, which had included large gains on the 2025 divestiture of the Healthcare RCM Business.
Operating cash flow strengthened to $38,414 for the nine‑month period, compared with $8,276 used in the prior year. Cash and cash equivalents declined to $2,647 as the company completed a $60,000 acquisition in the transportation market and repurchased 6,056,132 Class A shares for $137,884, funded in part by drawing $114,276 on its revolving credit facility. Goodwill increased to $282,284, and long‑lived intangible assets to $153,599, reflecting recent acquisitions.
i3 Verticals, Inc. reports modest revenue growth but lower profits from continuing operations as it reshapes its business mix. Revenue from continuing operations rose to $57.5M for the quarter and $110.2M for six months, driven mainly by software and related services.
Income from continuing operations declined to $2.7M before tax and $4.5M for six months, as operating and interest expenses increased and prior-year divested businesses are now reported as discontinued operations. Cash from operations improved to $24.2M, but cash on hand fell sharply as the company spent heavily on acquisitions and share repurchases.
The company acquired a transportation-market software business for $60M plus up to $20M in contingent consideration, adding $33.8M of goodwill. It also continued returning capital through repurchasing about 3.7 million Class A shares for roughly $89.3M, funded in part by drawing $81M on its revolving credit facility.
i3 Verticals, Inc. reported quarterly revenue of $52.7 million for the three months ended December 31, 2025, essentially flat versus $52.2 million a year earlier. Net income fell to $0.9 million from $3.1 million as operating income and discontinued operations both declined.
Continuing operations generated $1.6 million of operating income and $1.1 million of net income, while discontinued operations, primarily the previously sold Healthcare and Merchant Services businesses, produced a small net loss. Operating cash flow improved to $14.1 million, but cash and equivalents decreased to $37.5 million due to heavy capital returns.
The company repurchased 1.52 million Class A shares for $38.3 million under its 2025 program, significantly reducing additional paid-in capital and total equity. Earlier divestitures of the Healthcare and Merchant Services businesses brought in cash proceeds of $96.3 million and $439.5 million, respectively, and their results are now reported as discontinued operations.
i3 Verticals reported revenue of $51.9 million for the three months ended June 30, 2025, up from $46.2 million a year earlier, and $158.3 million for the nine months, up from $139.9 million. Revenue growth was driven by software and related services ($36.2M for the quarter) and proprietary payments ($13.1M for the quarter). The company showed improvement in continuing operations, narrowing the loss from $(14.4) million to $(1.0) million for the quarter, while consolidated net income was $18.4 million benefitting from discontinued operations.
Liquidity and capital structure were materially affected by strategic divestitures: the Healthcare RCM Business sale closed for $96.4 million in cash (subject to adjustments), with net proceeds reported as $96.1 million, and related transition services generated $3.9 million in the period. Net cash used in operating activities was $(8.3) million for the nine months, investing provided $78.8 million (primarily sale proceeds), and financing used $(104.3) million, including $37.6 million of share repurchases and $26.2 million to extinguish exchangeable notes. Total assets declined to $623.3 million from $730.7 million and total equity was $511.1 million.